These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 226561)

  • 1. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol.
    Ulick S; Levine LS; Gunczler P; Zanconato G; Ramirez LC; Rauh W; Rösler A; Bradlow HL; New MI
    J Clin Endocrinol Metab; 1979 Nov; 49(5):757-64. PubMed ID: 226561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
    Stewart PM; Corrie JE; Shackleton CH; Edwards CR
    J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess.
    Oberfield SE; Levine LS; Carey RM; Greig F; Ulick S; New MI
    J Clin Endocrinol Metab; 1983 Feb; 56(2):332-9. PubMed ID: 6296185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New findings in apparent mineralocorticoid excess.
    DiMartino-Nardi J; Stoner E; Martin K; Balfe JW; Jose PA; New MI
    Clin Endocrinol (Oxf); 1987 Jul; 27(1):49-62. PubMed ID: 2820623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparent mineralocorticoid excess: type I and type II.
    Mantero F; Palermo M; Petrelli MD; Tedde R; Stewart PM; Shackleton CH
    Steroids; 1996 Apr; 61(4):193-6. PubMed ID: 8732999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
    Rodríguez JA
    Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent mineralocorticoid excess causing hypertension and hypokalemia in children.
    New MI; Stoner E; DiMartino-Nardi J
    Clin Exp Hypertens A; 1986; 8(4-5):751-72. PubMed ID: 3463439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11 beta-Hydroxysteroid dehydrogenase deficit: a rare cause of arterial Hypertension. Diagnosis and therapeutic approach in two young brothers.
    Gourmelen M; Saint-Jacques I; Morineau G; Soliman H; Julien R; Fiet J
    Eur J Endocrinol; 1996 Aug; 135(2):238-44. PubMed ID: 8810740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for cortisol as the mineralocorticoid in the syndrome of apparent mineralocorticoid excess.
    Tedde R; Pala A; Melis A; Ulick S
    J Endocrinol Invest; 1992 Jun; 15(6):471-4. PubMed ID: 1401749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
    Al-Harbi T; Al-Shaikh A
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1083-8. PubMed ID: 23329753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent mineralocorticoid excess.
    Funder JW
    Endocrinol Metab Clin North Am; 1995 Sep; 24(3):613-21. PubMed ID: 8575412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess.
    Ulick S; Tedde R; Wang JZ
    J Clin Endocrinol Metab; 1992 Mar; 74(3):593-9. PubMed ID: 1740492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cortisol-cortisone shuttle and hypertension.
    Stewart PM; Edwards CR
    J Steroid Biochem Mol Biol; 1991; 40(4-6):501-9. PubMed ID: 1958552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent mineralocorticoid excess type II.
    Mantero F; Tedde R; Opocher G; Dessi Fulgheri P; Arnaldi G; Ulick S
    Steroids; 1994 Feb; 59(2):80-3. PubMed ID: 8191552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent mineralocorticoid excess and deficient 11 beta-oxidation of cortisol in a young female.
    Harinck HI; van Brummelen P; Van Seters AP; Moolenaar AJ
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):505-14. PubMed ID: 6094045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
    Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
    Odermatt A; Dick B; Arnold P; Zaehner T; Plueschke V; Deregibus MN; Repetto H; Frey BM; Frey FJ; Ferrari P
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess.
    Dave-Sharma S; Wilson RC; Harbison MD; Newfield R; Azar MR; Krozowski ZS; Funder JW; Shackleton CH; Bradlow HL; Wei JQ; Hertecant J; Moran A; Neiberger RE; Balfe JW; Fattah A; Daneman D; Akkurt HI; De Santis C; New MI
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2244-54. PubMed ID: 9661590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new form of the syndrome of apparent mineralocorticoid excess.
    Ulick S; Chan CK; Rao KN; Edassery J; Mantero F
    J Steroid Biochem; 1989 Jan; 32(1B):209-12. PubMed ID: 2913411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess.
    Ulick S; Tedde R; Mantero F
    J Clin Endocrinol Metab; 1990 Jan; 70(1):200-6. PubMed ID: 2403571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.